Cardiovascular risk assessment with oxidised LDL measurement in postmenopausal women receiving intranasal estrogen replacement therapy

Kurdoglu, Mertihan; YILDIRIM, MÜLAZİM; Kurdoglu, Zehra; ERDEM, AHMET; ERDEM, MEHMET; BİLGİHAN, AYŞE; Goktas, Bulent

doi:10.3109/09513590.2010.501879

Cardiovascular risk assessment with oxidised LDL measurement in postmenopausal women receiving intranasal estrogen replacement therapy

Copy For Citation

Kurdoglu M., YILDIRIM M., Kurdoglu Z., ERDEM A., ERDEM M., BİLGİHAN A., ...More

GYNECOLOGICAL ENDOCRINOLOGY, vol.27, no.8, pp.551-557, 2011 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 27 Issue: 8
Publication Date: 2011
Doi Number: 10.3109/09513590.2010.501879
Title of Journal : GYNECOLOGICAL ENDOCRINOLOGY
Page Numbers: pp.551-557

Abstract

Objective. To investigate the effect of intranasal estrogen replacement therapy administered to postmenopausal women alone or in combination with progesterone on markers of cardiovascular risk.